Village-Neuf, Switzerland

Guillaume Lemercier


Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Village-Neuf, FR (2014)
  • Village-Neuf, CH (2018)

Company Filing History:


Years Active: 2014-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Guillaume Lemercier

Introduction

Guillaume Lemercier is a notable inventor based in Village-Neuf, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of peptidomimetics. With a total of two patents to his name, his work focuses on innovative solutions for treating various diseases.

Latest Patents

Lemercier's latest patents include the development of template-fixed peptidomimetics as inhibitors of FPR1. These novel compounds have the potential to antagonize the biological effects of the receptor FPR1, making them valuable in treating inflammatory diseases, allergic conditions, and various immunological disorders. Additionally, he has worked on β-hairpin peptidomimetics that possess CXCR4 antagonizing properties, which can be utilized in preventing HIV infections and treating cancer and immunological diseases.

Career Highlights

Guillaume Lemercier is currently associated with Polyphor AG, where he continues to advance his research in the field of peptidomimetics. His innovative approaches and dedication to scientific research have positioned him as a key figure in medicinal chemistry.

Collaborations

Lemercier collaborates with esteemed colleagues such as Daniel Obrecht and Sophie Barthélémy, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Guillaume Lemercier's work exemplifies the intersection of innovation and medicinal chemistry, showcasing the potential of peptidomimetics in addressing critical health challenges. His contributions are paving the way for future advancements in therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…